World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
57
Citations
16235
World Ranking
3531
National Ranking
1392

Overview

James O. Kahn is affiliated with Stanford University in the United States and has contributed to the field of Medicine, with a focus on Emergency Medicine, Infectious Diseases, and Surgery.

Their research primarily addresses topics related to HIV/AIDS and cardiovascular health, including:

  • HIV-related health complications and treatments
  • HIV/AIDS drug development and treatment
  • Lipoproteins and Cardiovascular Health

Kahn has published work in venues such as UNC Libraries. One notable paper includes "Comparative Effectiveness of Fish Oil Versus Fenofibrate, Gemfibrozil, and Atorvastatin on Lowering Triglyceride Levels Among HIV-Infected Patients in Routine Clinical Care," published in 2020.

Their frequent co-authors are:

  • Mònica Muñoz
  • Wei Liu
  • Joseph A. Delaney
  • Elizabeth Brown
  • Michael J. Mugavero

Best Publications

  • Acute Human Immunodeficiency Virus Type 1 Infection

    James O. Kahn;Bruce D. Walker

  • HIV-1 protease inhibitors. A review for clinicians.

    Steven G. Deeks;Mark Smith;Mark Holodniy;James O. Kahn

  • Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

    Steven G. Deeks;Christina M. R. Kitchen;Lea Liu;Hua Guo

  • New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes

    Robert S. Janssen;Glen A. Satten;Susan L. Stramer;Bhupat D. Rawal

  • Time trends in primary HIV-1 drug resistance among recently infected persons.

    Robert M. Grant;Frederick M. Hecht;Maria Warmerdam;Lea Liu

  • AIDS-Associated Non-Hodgkin's Lymphoma in San Francisco

    Lawrence D. Kaplan;Donald I. Abrams;Ellen Feigal;Michael McGrath

  • Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

    Frederick M. Hecht;Robert M. Grant;Christos J. Petropoulos;Beth Dillon

  • Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection

    Marcus Altfeld;Eric S. Rosenberg;Raj Shankarappa;Joia S. Mukherjee

  • Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.

    Marcus Altfeld;Marylyn M. Addo;Eric S. Rosenberg;Frederick M. Hecht

  • A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection

    Kahn Jo;Lagakos Sw;Richman Dd;Cross A

  • Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.

    Clyde Thornsberry;Mark E. Jones;Mary L. Hickey;Yolanda Mauriz

  • Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

    Frederick M. Hecht;Michael P. Busch;Bhupat Rawal;Marcy Webb

  • Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.

    Patricia Barditch-Crovo;Steven G. Deeks;A. N. N. Collier;Sharon Safrin

  • Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy

    Richard T. D'Aquila;Victoria A. Johnson;Seth L. Welles;Anthony J. Japour

  • Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems

    Mari M Kitahata;Benigno Rodriguez;Richard Haubrich;Stephen Boswell

  • Predicting the unpredictable: Transmission of drug-resistant HIV

    S M Blower;A N Aschenbach;H B Gershengorn;J O Kahn

  • Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial.

    Lawrence D. Kaplan;James O. Kahn;Suzanne Crowe;Donald W Northfelt

  • Efficacy and Safety of Adefovir Dipivoxil With Antiretroviral Therapy: A Randomized Controlled Trial

    James Kahn;Stephen Lagakos;Michael Wulfsohn;Deborah Cherng

  • Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.

    Richard T. Davey;Robert L. Murphy;Frank M. Graziano;Stephen L. Boswell

  • Feasibility of Postexposure Prophylaxis (PEP) against Human Immunodeficiency Virus Infection after Sexual or Injection Drug Use Exposure: The San Francisco PEP Study

    James O. Kahn;Jeffrey N. Martin;Michelle E. Roland;Joshua D. Bamberger

Frequent Co-Authors

Frederick Hecht
Frederick Hecht University of California, San Francisco
Margaret A. Chesney
Margaret A. Chesney University of California, San Francisco
Paul A. Volberding
Paul A. Volberding University of California, San Francisco
Jeffrey N. Martin
Jeffrey N. Martin University of California, San Francisco
Steven M. Asch
Steven M. Asch Stanford University
Jay A. Levy
Jay A. Levy University of California, San Francisco
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Sally Blower
Sally Blower University of California, Los Angeles
Robert M. Grant
Robert M. Grant University of California, San Francisco
Thomas J. Coates
Thomas J. Coates University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career pathways, many of which can be enhanced by pursuing related online degrees. For those interested in healthcare and public health, exploring the fastest and easiest online mph programs can provide a flexible way to gain crucial skills without delaying career progress.

Some students may be interested in specialized careers like becoming a child life specialist, a role that offers meaningful interaction with children and families. Understanding the child.life specialist salary and job requirements is essential for evaluating this pathway’s potential.

Microbiology graduates facing challenges in their career paths, such as those with felony records, can find guidance through resources highlighting the best degrees for felons. These programs are designed to provide viable educational opportunities and promote social reintegration.

For those inclined towards holistic and integrative health, understanding how to become a functional medicine nurse practitioner offers a route combining microbiology knowledge with patient-centered care. Online degrees in nursing or health sciences can facilitate this transition.

Best Scientists Citing James O. Kahn

Trending Scientists

Recently Published Articles